AcquisitionOther
TransCode Therapeutics, Inc. acquired Polynoma LLC
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
TransCode Therapeutics, Inc. -> Polynoma LLC · $25 million
To expand its microRNA-based pipeline with Polynoma's Phase 3-ready seviprotimut-L for melanoma treatment.
Open source record (SEC) ↗